Neuroone Medical Technologies (NMTC) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.97% |
| Dec 31, 2025 | -7.81% |
| Sep 30, 2025 | -9.70% |
| Jun 30, 2025 | -8.34% |
| Mar 31, 2025 | -55.89% |
| Dec 31, 2024 | -43.12% |
| Sep 30, 2024 | -49.94% |
| Jun 30, 2024 | -30.20% |
| Mar 31, 2024 | -29.20% |
| Dec 31, 2023 | 46.40% |
| Sep 30, 2023 | 44.62% |
| Jun 30, 2023 | 44.20% |
| Mar 31, 2023 | 45.29% |
| Dec 31, 2022 | 55.66% |
| Sep 30, 2022 | 113.71% |
| Jun 30, 2022 | 244.37% |
| Mar 31, 2022 | 209.03% |
| Dec 31, 2021 | 73.43% |
| Sep 30, 2021 | 51.70% |
| Jun 30, 2021 | 47.59% |
| Mar 31, 2021 | 54.64% |
| Dec 31, 2020 | 31.61% |
| Sep 30, 2020 | 37.25% |
| Jun 30, 2020 | -212.64% |
| Mar 31, 2020 | -267.03% |
| Dec 31, 2019 | -158.76% |
| Sep 30, 2019 | -127.40% |
| Jun 30, 2019 | -40.05% |
| Mar 31, 2019 | 93.51% |
| Dec 31, 2018 | -293.31% |
| Dec 31, 2017 | -422.10% |
| Jun 30, 2017 | -87.83% |
| Mar 31, 2017 | -214.39% |
| Dec 31, 2016 | -106.37% |
| Sep 30, 2016 | -54.93% |
| Jun 30, 2016 | -57.11% |
| Mar 31, 2016 | -69.04% |
| Dec 31, 2015 | -67.84% |
| Dec 31, 2014 | -121.04% |
| Jun 30, 2014 | -5.03% |
| Dec 31, 2013 | -91.36% |